Image pharmaphorum Editor Views & Analysis How eligible patient numbers affect price of rare disease dr... Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Life Sciences Practice team explores in greater depth the situation for thes Views & Analysis Addressing leadership barriers for women in tech and pharma Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. Digital Deep Dive: Digital Health 2022 Following an unprecedented year of surging investment interest, the digital health industry is booming. Digital How a new investment is powering a revolution in clinical tr... Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. Load more results
Views & Analysis How eligible patient numbers affect price of rare disease dr... Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Life Sciences Practice team explores in greater depth the situation for thes
Views & Analysis Addressing leadership barriers for women in tech and pharma Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry.
Digital Deep Dive: Digital Health 2022 Following an unprecedented year of surging investment interest, the digital health industry is booming.
Digital How a new investment is powering a revolution in clinical tr... Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
